Sander, Beate; Hayden, Frederick G.; Gyldmark, Marlene; … - In: PharmacoEconomics 24 (2006) 4, pp. 373-386
Objectives: To assess the cost effectiveness and cost utility of preventing post-exposure influenza infection using the neuraminidase inhibitor oseltamivir from a healthcare payer's perspective in the UK. Methods: A simulation model was developed, based on clinical trial results and published...